Bluestar Genomics closes $70M Series C funding, expands scientific advisory board

Must Read

Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early cancer detection, today announced the company had raised $70 million in new equity funding. Led with the …

Latest News

Komnas HAM urges synergy to fight online scam-linked trafficking

Jakarta (ANTARA) - Indonesia's National Human Rights Commission (Komnas HAM) has called for stronger coordination among ministries and government...

More Articles Like This